Cambridge Biomedical Campus Information

The Cambridge Biomedical Campus is the largest centre of medical research and health science in Europe. The site is located at the southern end of Hills Road in Cambridge, England. Over 20,000 people work at the site and is home to a number of organisations including: Cambridge University Hospitals NHS Foundation Trust, Royal Papworth Hospital NHS Foundation Trust, Abcam, the Wellcome Trust, Cancer Research UK, the universitys medical school, the UK governments Medical Research Council and has National Institute for Health Research Biomedical Research Centre status. It is an accredited UK academic health science centre (Cambridge University Health Partners).

The Cambridge Biomedical Campus is home to the following institutes.

Addenbrookes Hospital is a large teaching hospital, and the central focus of the campus.

Papworth Hospital is due to move to new premises on the Cambridge Biomedical Campus in Spring 2019.

AstraZeneca’s global research and development facility is due to be based on the campus and will house a workforce of approximately 2,000 individuals. It will be home to both early and late-stage medicines discovery and development, and cover both small molecules and biologics. Research activities will span all preclinical functional groups, including antibody engineering, medicinal chemistry and high throughput screening.

The University of Cambridge Medical School, established in 1976.

The LMB is a molecular biology research institute funded by the UK Medical Research Council. It was founded in Cambridge in 1947 as the Unit for Research on the Molecular Structure of Biological Systems and moved to a site adjacent to Addenbrookes Hospital in 1962. A 27,000m2 replacement building close to the previous site was completed in 2012 and opened in May 2013.

The laboratory has won nine Nobel Prizes including the 1962 prize (Physiology or Medicine) awarded for the discovery of the double-helix structure of DNA.

The Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute or SCI is a virtual organisation composed of the Anne McLaren Laboratory for Stem Cell Biology and Regenerative Medicine and the Wellcome Trust Centre for Stem Cell Research, as well as University-based Principal Investigators working in neighbouring Cambridge institutes whose research is primarily focused on stem cell biology and/or translation. The SCI is principally funded by the Wellcome Trust and the Medical Research Council. The Wellcome Trust also funds the SCIs internationally competitive 4-Year PhD Programme in Stem Cell Biology and Medicine. Stem cell biology and regenerative medicine research is a designated University of Cambridge Strategic Initiative.

The aims of the SCI are:

The SCI was formed in 2012 following an £8m investment by the Wellcome Trust and the Medical Research Council. The SCI will eventually be housed in a purpose-built 8000m2 facility to be constructed on the Cambridge Biomedical Campus site.

The Cancer Research UK Cambridge Institute is one of four core funded Cancer Research UK Institutes and a department of the University of Cambridge. In 2018, the department received an annual budget of £45 million, £27.8 million of which came from Cancer Research UK. The Institute offers highly competitive PhD programmes; both studentships and clinical research training fellowships (for aspiring clinical academics), attracting applicants from the UK and around the world. Cancer research is a designated University of Cambridge Strategic Initiative.

Research in the Institute focuses primarily on Tumour Ecology and Evolution, with investigations across four main areas:

The centre was officially opened by Queen Elizabeth II in February 2007. In 2018, Professor Gregory Hannon was announced as the new Director, taking over from Professor Simon Tavaré.

Senior Group Leader at the Institute, Professor Richard Gilbertson, is the Director of the Cancer Research UK Cambridge Centre, a network that encourages local collaborations between universities, NHS hospitals, and other research organisations.

The CIMR is a cross-departmental institute in the University of Cambridge, receiving funding from the Wellcome Trust. Research is focused on four main areas: misfolded proteins and disease, intracellular membrane traffic, autoimmune disease and haematopoietic stem cell biology.

The Wolfson Brain Imaging Centre was created in 1995 to develop and apply advanced imaging methods to patients with traumatic brain injury. It is unique in being co-located with the Neurosciences Critical Care Unit of Addenbrookes Hospital. Since its establishment it has become an internationally leading Positron Emission Tomography and Magnetic Resonance Imaging centre.

The Hutchison/MRC Research Centre is a cancer research centre housing researchers from the University of Cambridge Department of Oncology, the MRC Cancer Cell Unit, and the University of Cambridge "Cambridge Molecular Therapeutics Programme". It was built in 2001 with funding from the Medical Research Council and a donation to the University of Cambridge from Hutchison Whampoa Ltd. The Hutchison/MRC Research Centre is a member institute of the Cambridge Cancer Centre, a virtual organisation of Cambridge researchers whose work has current or potential application to cancer research.

The Rosie Hospital is Cambridges first purpose-built maternity hospital, opened in October 1983. A multimillion-pound extension of the Rosie Hospital was completed in 2012.

Complete article available at this page.